Anika Therapeutics, Inc. (ANIK)
NASDAQ: ANIK · Real-Time Price · USD
14.96
+0.84 (5.95%)
At close: Mar 9, 2026, 4:00 PM EDT
14.96
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:10 PM EDT
Anika Therapeutics Market Cap
Anika Therapeutics has a market cap or net worth of $200.48 million as of March 9, 2026. Its market cap has decreased by -22.45% in one year.
Market Cap
200.48M
Enterprise Value
164.95M
1-Year Change
-22.45%
Ranking
Category
Stock Price
$14.96
Market Cap Chart
Since December 1, 1998, Anika Therapeutics's market cap has increased from $51.20M to $200.48M, an increase of 291.55%. That is a compound annual growth rate of 5.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 189.20M | 36.51% |
| Dec 31, 2025 | 138.60M | -42.51% |
| Dec 31, 2024 | 241.10M | -27.34% |
| Dec 29, 2023 | 331.80M | -23.27% |
| Dec 30, 2022 | 432.40M | -16.41% |
| Dec 31, 2021 | 517.30M | -19.59% |
| Dec 31, 2020 | 643.30M | -13.06% |
| Dec 31, 2019 | 739.90M | 54.92% |
| Dec 31, 2018 | 477.60M | -39.57% |
| Dec 29, 2017 | 790.40M | 10.39% |
| Dec 30, 2016 | 716.00M | 28.18% |
| Dec 31, 2015 | 558.60M | -5.47% |
| Dec 31, 2014 | 590.90M | 12.00% |
| Dec 31, 2013 | 527.60M | 284.27% |
| Dec 31, 2012 | 137.30M | 2.85% |
| Dec 30, 2011 | 133.50M | 48.50% |
| Dec 31, 2010 | 89.90M | 2.98% |
| Dec 31, 2009 | 87.30M | 152.31% |
| Dec 31, 2008 | 34.60M | -78.71% |
| Dec 31, 2007 | 162.50M | 14.12% |
| Dec 29, 2006 | 142.40M | 16.06% |
| Dec 30, 2005 | 122.70M | 31.51% |
| Dec 31, 2004 | 93.30M | -4.11% |
| Dec 31, 2003 | 97.30M | 892.86% |
| Dec 31, 2002 | 9.80M | -1.01% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Evolus | 359.78M |
| Organogenesis Holdings | 358.91M |
| Akebia Therapeutics | 340.21M |
| Lifecore Biomedical | 260.77M |
| Journey Medical | 258.40M |
| Organigram Global | 199.47M |
| Aurora Cannabis | 199.05M |
| BGM Group | 191.32M |